The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation
Abstract
Macrophage phenotype and activation are regulated by cytokines that use the Jak-STAT signaling pathway, microbial recognition receptors that include TLRs, and immunoreceptors that signal via ITAM motifs. The amplitude and qualitative nature of macrophage activation are determined by crosstalk among these signaling pathways. Basal ITAM signaling restrains macrophage responses to TLRs and other activating ligands, whereas strong ITAM signals synergize with the same ligands to activate cells strongly. Similarly, basal ITAM signaling augments IFN signaling and function of receptor activator of NF-κB, but extensive ITAM activation inhibits Jak-STAT signaling. Thus, intensity and duration of ITAM signaling determine whether ITAM-coupled receptors augment or attenuate TLR and Jak-STAT responses. IFN-γ synergizes with TLRs in part by suppressing TLR-induced feedback inhibition, mediated by IL-10 and Stat3, by a mechanism that depends on glycogen synthase kinase (GSK)3 regulation of AP-1 and CREB. IFN-γ suppresses TLR2 and TLR4 induction/activation of AP-1 by overlapping mechanisms that include regulation of MAPKs, GSK3-dependent suppression of DNA binding, and decreased Fos and Jun protein expression and stability. IFN-γ suppression of TLR-induced activation of AP-1 and downstream target genes challenges current concepts about the inflammatory role of AP-1 proteins in macrophage activation and is consistent with a role for AP-1 in the generation of noninflammatory osteoclasts. Jak-STAT, TLR, and ITAM pathways are basally active in macrophages and strongly induced during innate responses. Thus, signal transduction crosstalk is regulated in a dynamic manner, which differs under homeostatic and pathologic conditions, and dysregulation of signal transduction crosstalk may contribute to pathogenesis of chronic inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cuzzocrea, S., Mazzon, E., Paola, R. D., Muià, C., Crisafulli, C., Dugo, L., Collin, M., Britti, D., Caputi, A. P., & Thiemermann, C. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.03.005 · Cited by 89
RetractedPathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
The Cell Biology of Macrophage Activation
Adams, D. (1984) · Annual Review of Immunology · doi:10.1146/annurev.immunol.2.1.283 · Cited by 1,604
The molecular understanding of osteoclast differentiation
Asagiri, M., & Takayanagi, H. (2007) · Bone · doi:10.1016/j.bone.2006.09.023 · Cited by 1,363
Macrophage Polarization Comes of Age
Mantovani, Sica, & Locati, M. (2005) · Immunity · doi:10.1016/j.immuni.2005.10.001 · Cited by 1,259 · cited 1×
“[ 2 ]). M2 macrophages are also important for wound healing and tissue remodeling, which follow infection or tissue injury.”
BackgroundTREM-1 amplifies inflammation and is a crucial mediator of septic shock
Bouchon, A., Facchetti, F., Weigand, M. A., & Colonna, M. (2001) · Nature · doi:10.1038/35074114 · Cited by 1,090
Martin, M., Rehani, K., Jope, R. S., & Michalek, S. M. (2005) · Nature Immunology · doi:10.1038/ni1221 · Cited by 1,080
Fcγ Receptors: Old Friends and New Family Members
Nimmerjahn, F., & Ravetch, J. V. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.010 · Cited by 1,072
Boyle, W. J., Smeal, T., Defize, L. H. K., Angel, P., Woodgett, J. R., Karin, M., & Hunter, T. (1991) · Cell · doi:10.1016/0092-8674(91)90241-p · Cited by 1,055
p38-dependent marking of inflammatory genes for increased NF-κB recruitment
Saccani, S., Pantano, S., & Natoli, G. (2002) · Nature Immunology · doi:10.1038/ni748 · Cited by 693
Cutting Edge: TREM-2 Attenuates Macrophage Activation
Turnbull, I. R., Gilfillan, S., Cella, M., Aoshi, T., Miller, M., Piccio, L., Hernandez, M., & Colonna, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3520 · Cited by 688
The TREM receptor family and signal integration
Klesney-Tait, J., Turnbull, I. R., & Colonna, M. (2006) · Nature Immunology · doi:10.1038/ni1411 · Cited by 589
Fos/AP‐1 proteins in bone and the immune system
Wagner, E. F., & Eferl, R. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00332.x · Cited by 537
Friendly and dangerous signals: is the tissue in control?
Matzinger, P. (2007) · Nature Immunology · doi:10.1038/ni0107-11 · Cited by 532
A weak signal for strong responses: interferon-alpha/beta revisited
Taniguchi, T., & Takaoka, A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35073080 · Cited by 483
Dillon, S., Agrawal, A., Van Dyke, T., Landreth, G., McCauley, L., Koh, A., Maliszewski, C., Akira, S., & Pulendran, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4733 · Cited by 460
Hamerman, J. A., Jarjoura, J. R., Humphrey, M. B., Nakamura, M. C., Seaman, W. E., & Lanier, L. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2051 · Cited by 440
IFN-γ Suppresses IL-10 Production and Synergizes with TLR2 by Regulating GSK3 and CREB/AP-1 Proteins
Hu, X., Paik, P. K., Chen, J., Yarilina, A., Kockeritz, L., Lu, T. T., Woodgett, J. R., & Ivashkiv, L. B. (2006) · Immunity · doi:10.1016/j.immuni.2006.02.014 · Cited by 406
Self-citationPlexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis
Takegahara, N., Takamatsu, H., Toyofuku, T., Tsujimura, T., Okuno, T., Yukawa, K., Mizui, M., Yamamoto, M., Prasad, D. V. R., Suzuki, K., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1416 · Cited by 320
Role of STAT3 in Type I Interferon Responses
Ho, H. H., & Ivashkiv, L. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511797200 · Cited by 302
Self-citationSignal integration between IFNγ and TLR signalling pathways in macrophages
Schroder, K., Sweet, M. J., & Hume, D. A. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.05.007 · Cited by 288
Activating and inhibitory functions of DAP12
Turnbull, I. R., & Colonna, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2014 · Cited by 273
New insights into the regulation of TLR signaling
Miggin, S. M., & O’Neill, L. A. J. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105672 · Cited by 267
Role of ITAM‐containing adapter proteins and their receptors in the immune system and bone
Humphrey, M. B., Lanier, L. L., & Nakamura, M. C. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00325.x · Cited by 241
Strehl, B., Seifert, U., Krüger, E., Heink, S., Kuckelkorn, U., & Kloetzel, P. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00308.x · Cited by 234
DAP12-Deficient Mice Fail to Develop Autoimmunity Due to Impaired Antigen Priming
Bakker, A. B. H., Hoek, R. M., Cerwenka, A., Blom, B., Lucian, L., McNeil, T., Murray, R., Phillips, J. H., Sedgwick, J. D., & Lanier, L. L. (2000) · Immunity · doi:10.1016/s1074-7613(00)00034-0 · Cited by 232
Underhill, D. M., & Goodridge, H. S. (2007) · Trends in Immunology · doi:10.1016/j.it.2006.12.004 · Cited by 187
Tomasello, E., Desmoulins, P.-O., Chemin, K., Guia, S., Cremer, H., Ortaldo, J., Love, P., Kaiserlian, D., & Vivier, E. (2000) · Immunity · doi:10.1016/s1074-7613(00)00035-2 · Cited by 159
Park-Min, K.-H., Serbina, N. V., Yang, W., Ma, X., Krystal, G., Neel, B. G., Nutt, S. L., Hu, X., & Ivashkiv, L. B. (2007) · Immunity · doi:10.1016/j.immuni.2006.11.010 · Cited by 158
Self-citationInhibition of Immune Responses by ITAM-Bearing Receptors
Hamerman, J. A., & Lanier, L. L. (2006) · Science s STKE · doi:10.1126/stke.3202006re1 · Cited by 143
Tassiulas, I. O., Hu, X., Ho, H. H., Kashyap, Y., Paik, P. K., Hu, Y., Lowell, C. A., & Ivashkiv, L. B. (2004) · Nature Immunology · doi:10.1038/ni1126 · Cited by 113
Self-citationDAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis
Turnbull, I. R., McDunn, J. E., Takai, T., Townsend, R. R., Cobb, J. P., & Colonna, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050986 · Cited by 99
Stimulatory and inhibitory signals originatingfrom the macrophage Fcγ receptors
Gerber, J. S., & Mosser, D. M. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(00)01360-5 · Cited by 86
Antoniv, T. T., & Ivashkiv, L. B. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22055 · Cited by 79
Self-citationInhibition of Interleukin 10 Signaling after Fc Receptor Ligation and during Rheumatoid Arthritis
Ji, J.-D., Tassiulas, I. O., Park‐Min, K., Aydin, A., Mecklenbräuker, I., Tarakhovsky, A., Pricop, L., Salmon, J. E., & Ivashkiv, L. B. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021820 · Cited by 79
Self-citationLee, I.-H., Li, W. P., Hisert, K. B., & Ivashkiv, L. B. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.9.1263 · Cited by 75
Self-citationMitsuhashi, M., Liu, J., Cao, S., Shi, X., & Ma, X. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1203641 · Cited by 62
Transient Inhibition of Interleukin 4 Signaling by T Cell Receptor Ligation
Zhu, J., Huang, H., Guo, L., Stonehouse, T. J., Watson, C. J., Hu‐Li, J., & Paul, W. E. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1125 · Cited by 61
Hu, X., Ho, H. H., Lou, O., Hidaka, C., & Ivashkiv, L. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.131 · Cited by 56
Self-citationInhibition of IFN-α signaling by a PKC- and protein tyrosine phosphatase SHP-2-dependent pathway
Du, Z., Shen, Y., Yang, W., Mecklenbräuker, I., Neel, B. G., & Ivashkiv, L. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408854102 · Cited by 51
Self-citationMochizuki, A., Takami, M., Kawawa, T., Suzumoto, R., Sasaki, T., Shiba, A., Tsukasaki, H., Zhao, B., Yasuhara, R., Suzawa, T., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4360 · Cited by 38
Xu, W., Nair, J. S., Malhotra, A., & Zhang, J. J. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.113 · Cited by 21
Cited by
Hu, X., & Ivashkiv, L. B. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.002 · Cited by 928
Self-citationBansal, T., Alaniz, R. C., Wood, T. K., & Jayaraman, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906112107 · Cited by 868
Zhou, D., Huang, C., Lin, Z., Zhan, S., Kong, L., Fang, C., & Li, J. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.004 · Cited by 778
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Wu, A., Wei, J., Kong, L.-Y., Wang, Y., Priebe, W., Qiao, W., Sawaya, R., & Heimberger, A. B. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq082 · Cited by 691
the IBSEN study group, Franke, A., Balschun, T., Karlsen, T. H., Sventoraityte, J., Nikolaus, S., Mayr, G., Domingues, F. S., Albrecht, M., Nothnagel, M., et al. (2008) · Nature Genetics · doi:10.1038/ng.221 · Cited by 591
Metadata
- Authors
- Hu, X., Chen, J., Wang, L., & Ivashkiv, L. B.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-05-14
- Volume
- 82
- Issue
- 2
- Pages
- 237-243
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2120247510
- Cited by
- 296
- References
- 44
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.